These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3925873)

  • 41. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 42. General principles of antimicrobial therapy.
    Hermans PE
    Mayo Clin Proc; 1977 Oct; 52(10):603-10. PubMed ID: 20538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].
    Ganczarski A; Augustyniak G; Brauner G; Prelich A; Stapor K
    Przegl Lek; 1973; 30(3):303-7. PubMed ID: 4633373
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents].
    Sukhodol'skaia AE; Chaĭkovskaia VL
    Antibiotiki; 1974 Jul; 19(7):630-3. PubMed ID: 4618771
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug treatments for prosthetic joint infections in the era of multidrug resistance.
    Perez-Jorge C; Gomez-Barrena E; Horcajada JP; Puig-Verdie L; Esteban J
    Expert Opin Pharmacother; 2016 Jun; 17(9):1233-46. PubMed ID: 27054293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Resistance to chemotherapy of aerobic bacteria from nonspecific odontogenic infections].
    Oehring H; Schumann D; Karl P; Knappe U; Gruhn I
    Zahn Mund Kieferheilkd Zentralbl; 1976; 64(6):580-7. PubMed ID: 188271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In-vitro activity of cefotaxime].
    Knothe H
    Wien Klin Wochenschr Suppl; 1983; 142():4-7. PubMed ID: 6316671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Measurement of increasing antibiotic-resisnce in cases of bacterial synergism due to mixed pseudomonas and enteroccocus infections].
    Pérez-Ureña MT; Iriarte MT
    Rev Clin Esp; 1969 Jun; 113(5):435-40. PubMed ID: 5800550
    [No Abstract]   [Full Text] [Related]  

  • 49. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study.
    Tato M; García-Castillo M; Bofarull AM; Cantón R;
    Int J Antimicrob Agents; 2015 Nov; 46(5):502-10. PubMed ID: 26315199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Netilmicin in urinary tract infections.
    Svare J; Johnsen NJ; Vesterhauge S; Lund F; Thomsen J; Vejlsgaard R
    Scand J Infect Dis Suppl; 1980; Suppl 23():132-4. PubMed ID: 6937957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In-vitro antibiotic resistance of hospital and non-hospital strains of Pseudomonas aeruginosa].
    Ceddia T; Marinucci MC; Parravano N
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):529-33. PubMed ID: 121701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental endocarditis and fosfomycin.
    Rodríguez A; Vicente MV; Olay T
    Drugs Exp Clin Res; 1985; 11(1):55-62. PubMed ID: 3836112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the in vitro susceptibility and emergence of mutants resistant to ciprofloxacin among multidrug resistant clinical isolates.
    Lopes CA; Mendes RP; Curi PC; Watanabe DS; Decarlis RM; Horácio A; Michelin LA; Placidelli BA
    Rev Latinoam Microbiol; 1993; 35(4):345-9. PubMed ID: 8066328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EUCAST breakpoints can be used to interpret direct susceptibility testing of Enterobacteriaceae from urine samples.
    Sundqvist M; Olafsson J; Matuschek E
    APMIS; 2015 Feb; 123(2):152-5. PubMed ID: 25351570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F; Rossi A; De Palma L; Spagnolo N
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram.
    Mizuta M; Linkin DR; Nachamkin I; Fishman NO; Weiner MG; Sheridan A; Lautenbach E
    Infect Control Hosp Epidemiol; 2006 Apr; 27(4):413-5. PubMed ID: 16622822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 59. [Acquired antibiotic resistance in Madagascar: first evaluation].
    Decousser JW; Pfister P; Xueref X; Rakoto-Alson O; Roux JF
    Med Trop (Mars); 1999; 59(3):259-65. PubMed ID: 10701204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
    Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
    Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.